Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - HK
$ 6.13
0.822 %
$ 79.8 M
Market Cap
-19.16
P/E
BALANCE SHEET
8.44 M
ASSETS
220 K
LIABILITIES
8.22 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Regencell Bioscience Holdings Limited
| Current Assets | 8.11 M |
| Cash & Short-Term Investments | 7.96 M |
| Receivables | 153 K |
| Other Current Assets | 0 |
| Non-Current Assets | 324 K |
| Long-Term Investments | 0 |
| PP&E | 227 K |
| Other Non-Current Assets | 97.7 K |
| Current Liabilities | 194 K |
| Accounts Payable | 0 |
| Short-Term Debt | 59.8 K |
| Other Current Liabilities | 134 K |
| Non-Current Liabilities | 25.9 K |
| Long-Term Debt | 25.9 K |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Jun-2024 | Jun-2023 | Jun-2022 | Jun-2021 | Jun-2020 | Jun-2019 | Dec-2017 | Dec-2016 | Dec-2015 | Jan-2015 | Dec-2013 | Dec-2012 | Dec-2010 | Dec-2009 | Jan-2009 | Dec-2007 | Dec-2006 | Dec-2004 | Jan-2004 | Dec-2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash & Cash Equivalents | 3.0 | 1.6 | 6.4 | 59.4 K | 0.4 | 0.2 | 228.8 | 246.5 | 219.6 | 147.1 | 280.9 | 109.5 | 205.3 | 328.1 | 170.0 | 435.0 | 162.0 | 243.0 | 288.0 | 276.0 |
| Short Term Investments | 5.0 | 10.0 | 10.0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.8 | 7.0 | 0 | 6.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0.2 | 0 | 0 | 0 | 0 | 0 | 184.0 | 155.1 | 153.1 | 0 | 129.4 | 104.3 | 0 | 69.0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 56.5 K | 27.6 K | 7.44 K | 0 | 0 | 22.9 | 20.9 | 22.4 | 17.8 | 19.0 | 17.8 | 14.7 | 12.3 | 8.0 | 8.0 | 8.0 | 7.0 | 6.0 | 6.0 |
| Other Current Assets | 0 | 0.1 | 27.6 K | 7.44 K | 0 | 0 | 27.6 | 24.4 | 43.1 | 172.7 | 28.8 | 26.2 | 120.5 | 19.5 | 95.0 | 82.0 | 71.0 | 71.0 | 82.0 | 107.0 |
| Total Current Assets | 8.1 | 11.6 | 16.4 | 66.8 K | 0.4 | 0.2 | 463.3 | 446.9 | 438.2 | 341.4 | 465.1 | 257.8 | 346.5 | 428.9 | 273.0 | 525.0 | 241.0 | 321.0 | 376.0 | 389.0 |
| PP&E | 0.2 | 0.9 | 1.5 | 81.9 K | 0.1 | 0 | 1 513.2 | 1 390.1 | 1 404.2 | 1 458.9 | 1 509.6 | 1 463.2 | 1 690.5 | 1 818.7 | 3 018.0 | 2 734.0 | 2 684.0 | 2 391.0 | 2 123.0 | 1 815.0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 43.6 | 46.0 | 50.2 | 53.9 | 57.7 | 27.8 | 22.2 | 11.7 | 15.0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 345.8 | 327.0 | 328.7 | 320.4 | 320.4 | 267.8 | 178.8 | 178.8 | 178.0 | 181.0 | 214.0 | 213.0 | 197.0 | 227.0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 97.7 K | 0.1 | 0.1 | 0.2 | 18.7 K | 0 | 422.5 | 379.4 | 373.8 | 341.5 | 319.3 | 192.9 | 173.4 | 121.5 | (885.0) | (806.0) | (671.0) | (383.0) | (225.0) | (121.0) |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 8.4 | 12.6 | 18.0 | 0.3 | 0.5 | 0.2 | 2 842.9 | 2 645.7 | 2 632.3 | 2 539.5 | 2 704.7 | 2 209.5 | 2 492.6 | 2 637.7 | 2 599.0 | 2 634.0 | 2 468.0 | 2 542.0 | 2 471.0 | 2 310.0 |
| LIABILITIES | ||||||||||||||||||||
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 232.2 | 194.8 | 229.7 | 165.7 | 170.2 | 157.0 | 162.4 | 198.5 | 162.0 | 183.0 | 168.0 | 182.0 | 194.0 | 154.0 |
| Short Term Debt | 59.8 K | 0.4 | 0.4 | 3.7 | 3.1 | 2.1 | 26.6 | 25.5 | 27.4 | 26.6 | 29.8 | 22.0 | 95.8 | 17.1 | 77.0 | 0 | 52.0 | 56.0 | 47.0 | 0 |
| Other Current Liabilities | 0.1 | 0.2 | 0.2 | 0.7 | 95 K | 0 | 116.4 | 97.0 | 90.8 | 82.9 | 111.0 | 92.7 | 112.3 | 87.0 | 113.0 | 280.0 | 263.0 | 345.0 | 119.0 | 146.0 |
| Total Current Liabilities | 0.2 | 0.6 | 0.6 | 4.3 | 3.2 | 2.1 | 561.4 | 510.0 | 551.3 | 477.0 | 506.4 | 387.5 | 469.0 | 396.5 | 366.0 | 527.0 | 556.0 | 644.0 | 412.0 | 304.0 |
| Long Term Debt | 25.9 K | 25.4 K | 0.4 | 0 | 0 | 0 | 2 339.4 | 2 197.1 | 2 228.3 | 2 238.8 | 2 187.7 | 1 912.4 | 1 897.7 | 1 892.6 | 77.0 | 54.0 | 61.0 | 55.0 | 71.0 | 109.0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19.2 | 0 | 7.7 | 14.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 393.3 | 365.2 | 315.1 | 208.2 | 207.9 | 198.3 | 195.7 | 254.3 | 144.0 | 127.0 | 91.0 | 81.0 | 64.0 | 49.0 |
| Total Liabilities | 0.2 | 0.6 | 0.9 | 4.3 | 3.2 | 2.1 | 3 698.7 | 3 484.6 | 3 509.9 | 3 434.3 | 3 418.1 | 2 906.3 | 2 982.9 | 2 884.6 | 2 841.0 | 2 753.0 | 2 489.0 | 2 471.0 | 1 673.0 | 1 036.0 |
| EQUITY | ||||||||||||||||||||
| Common Stock | 130 | 130 | 130 | 100 | 100 | 100 | 100 K | 100 K | 100 K | 100 K | 100 K | 100 K | 100 K | 100 K | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (21.6) | (17.3) | (11.4) | (4.0) | (2.7) | (1.8) | 70.9 | 96.5 | 64.2 | 48.4 | 71.8 | 1.4 | 9.4 | 47.0 | 24.0 | 42.0 | 30.0 | 23.0 | 64.0 | 74.0 |
| Other Accumulative Comprehensive Income/Loss | 45.8 K | 86.7 K | 0 | 0 | 0 | 0 | (2 238.5) | (2 146.7) | (2 001.4) | (1.5) | (2.4) | (4.3) | (12.2) | (1 246.4) | (9.0) | (1.0) | 13.0 | (5.0) | 0 | 0 |
| Total Equity | 8.2 | 12.0 | 17.1 | (4.0) | (2.7) | (1.8) | (855.9) | (839.1) | (877.8) | (894.8) | (713.4) | (696.8) | (490.3) | (246.1) | (241.0) | (119.0) | (22.0) | 69.0 | 794.0 | 1 270.0 |
| Total Liabilities and Equity | 8.4 | 12.6 | 18.0 | 0.3 | 0.5 | 0.2 | 2 842.8 | 2 645.5 | 2 632.1 | 2 539.5 | 2 704.7 | 2 209.5 | 2 492.6 | 2 638.5 | 2 599.0 | 2 634.0 | 2 468.0 | 2 542.0 | 2 471.0 | 2 310.0 |
| SHARES OUTSTANDING | ||||||||||||||||||||
| Common Shares Outstanding | 13.0 | 13.0 | 13.0 | 12.6 | 12.6 | 12.6 | 156.3 | 156.8 | 156.5 | 155.3 | 154.8 | 154.2 | 153.4 | 153.1 | 1.2 | 5.8 | 1.3 | 143.9 | 138.1 | 141.0 |